YMRC
ABMD

Yorktown Management & Research Company’s Abiomed Inc ABMD Stock Holding History

Yorktown Management & Research Company’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,550
Closed -$381K – 227
2022
Q3 		$381K Hold
1,550
– – 0.49% 74
2022
Q2 		$384K Hold
1,550
– – 0.5% 87
2022
Q1 		$513K Hold
1,550
– – 0.44% 93
2021
Q4 		$557K Hold
1,550
– – 0.38% 106
2021
Q3 		$505K Hold
1,550
– – 0.38% 100
2021
Q2 		$484K Hold
1,550
– – 0.38% 107
2021
Q1 		$494K Hold
1,550
– – 0.41% 75
2020
Q4 		$503K Hold
1,550
– – 0.45% 70
2020
Q3 		$429K Hold
1,550
– – 0.4% 79
2020
Q2 		$374K Buy
+1,550
New +$311K 0.34% 82
2018
Q4 		– Sell
-2,358
Closed -$1.06M – 359
2018
Q3 		$1.06M Sell
2,358
-529
-18% -$209K 0.31% 95
2018
Q2 		$1.18M Buy
2,887
+337
+13% +$122K 0.34% 80
2018
Q1 		$742K Sell
2,550
-2,600
-50% -$659K 0.22% 109
2017
Q4 		$965K Hold
5,150
– – 0.28% 93
2017
Q3 		$868K Buy
+5,150
New +$779K 0.23% 78

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Yorktown Management & Research Company's ABMD Position: Q4 2022 in Review

Yorktown Management & Research Company sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,550 shares — an estimated $381K sold.

Yorktown Management & Research Company first reported a position in ABMD in Q3 2017 and held it in 15 quarters. The position peaked at $1.18M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Yorktown Management & Research Company reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Yorktown Management & Research Company sold 1,550 Abiomed Inc shares in Q4 2022, an estimated $381K.
  • Yorktown Management & Research Company first reported a position in Abiomed Inc in Q3 2017 and held it in 15 quarters.
  • Yorktown Management & Research Company's Abiomed Inc position peaked at $1.18M in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Yorktown Management & Research Company's 13F filing for Q4 2022, filed 26 Jan 2023.